Kurma Partners Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 13

Professionals
  • Investments
  • 116

  • Portfolio
  • 51

  • Exits
  • 28

Exits

Kurma Partners General Information

Description

Founded in 2009, Kurma Partners is a venture capital firm headquartered in Paris, France. The firm seeks to invest from pre-seed to growth capital through its venture capital funds as well as via strategic partnerships with prestigious European research and medical institutions in the healthcare, and biotechnology sectors.

Contact Information

Year Founded
2009
Investor Status
Actively Seeking New Investments
Trade Association
French Venture Capital Association (AFIC)
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 24, Rue Royale
  • 5th Floor
  • 75008 Paris
  • France
+33 01 00 00 00 00

Kurma Partners Investments (116)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Ganymed Robotics 07-Jul-2022 Early Stage VC 0000 Surgical Devices Generating Revenue
000000 00000000000 30-Jun-2022 00000 00000 0000 Drug Discovery Generating Revenue 0000000 000000 00.0
0000000 0000000000 10-Jun-2022 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2 0é00 0000000 00.0
0000000 (00000 000 05-Jun-2022 0000 00000 00.000 Other Healthcare Technology Systems Generating Revenue 00000000 00000
00000000 10-May-2022 00000 00000 000.00 Other Devices and Supplies Generating Revenue 0000-0000ç000 00000000
0000 00000000 11-Apr-2022 00000 00000 00.00 Financial Software Startup
00000 0000000 03-Feb-2022 00000 00000 00.000 Diagnostic Equipment Generating Revenue 00000000 0000000
0000 000000000000 27-Jan-2022 0000 00000 00.000 Monitoring Equipment Generating Revenue 00000 000000
Armgo Pharma 20-Dec-2021 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2 00000 0000000 00
Sunrise (Monitoring Equipment) 15-Dec-2021 Early Stage VC 00.000 Monitoring Equipment Generating Revenue 00000000 0000000
You’re viewing 10 of 116 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kurma Partners Exits (28)

Company Name Exit Date Exit Type Exit Size
IO Biotech 05-Nov-2021 IPO 00000
00000 13-Sep-2021 0000000000
00000000 000000000 30-Jul-2021 000000000000000000 00000
000000000 05-Feb-2021 000 00000
00000000 000000000 22-Jan-2020 000000000000000000
0000000 000000 24-Sep-2018 000 000.00
00000 000000000000 01-Sep-2018 000000000000000000
0000-00 19-Apr-2018 000000000000000000 00000
Orphazyme 21-Nov-2017 IPO 000.00
Key Neurosciences 17-Aug-2017 Bankruptcy: Liquidation
You’re viewing 10 of 28 exits. Get the full list »

Kurma Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Kurma Partners Team (35)

Name Title Deals Funds Boards Office
Sylvain Cascarino Chief Financial Officer & Partner 0 Paris, France
Rémi Droller Ph.D Managing Partner 00 00 0 Paris, France
Thierry Laugel Ph.D Managing Partner 00 0 0 Paris, France
Vanessa Malier Managing Partner 00 00 0 Paris, France
Alain Munoz Ph.D Venture Partner 0 0 0 Paris, France
You’re viewing 5 of 35 team members. Get the full list »

Kurma Partners Co-Investors (168)

Name With Exits Lead Partner Series Industry
Idinvest Partners 20 0 0 Series chart Industry bar
Bpifrance 00 00 Series chart Industry bar
Eurazeo 0 0 Series chart Industry bar
EQT Life Sciences 0 0 Series chart Industry bar
Pontifax Venture Capital 0 0 Series chart Industry bar
You’re viewing 5 of 168 co-investors. Get the full list »